Lybrate.com has a nexus of the most experienced Endocrinologists in India. You will find Endocrinologists with more than 35 years of experience on Lybrate.com. Find the best Endocrinologists online in Hyderabad. View the profile of medical specialists and their reviews from other patients to make an informed decision.
Book Clinic Appointment
Treatment Of Erectile Dysfunction
Treatment Of Male Sexual Problems
Treatment Of Female Sexual Problems
Thyroid Problems Treatment
Thyroid Disorder Treatment
Diabetic Diet Counseling
Urinary Incontinence (Ui) Treatment
Pre And Post Delivery Care
Sperm Donor Program
Adult Diabetes Treatment
Type 1 Diabetes Treatment
Submit a review for Dr. Md. Yousuf KhanYour feedback matters!
Hiii doctor I am 27 year old my height 5.6 and weight 55 I want to conceive a baby but I have thyroid problem not to high tsh 6.2 and below so if I conceive is it any prob in future?
Sir, I am a diabetic since last 22 years with blood pressure. Taking huminsulin 50: 50 37 units in morning and 35 units in evening. Amryl 3, jalra 50 and telma 40 in morning and still have uncontrolled blood sugar. I am the patient of hyper acidity and daily takes pantocid dsr in morning still feel breathlessness frequently. I take home made food only with minimum spices and fat.
Afrezza - the only inhaled insulin for diabetes.
Afrezza® is an inhaled human insulin indicated to help improve glycemic control in adults with diabetes mellitus.
Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The product consists of a dry formulation of human insulin delivered from a small and portable inhaler.
Administered at the beginning of a meal, afrezza dissolves rapidly upon inhalation to the lung and delivers insulin quickly to the bloodstream. Peak insulin levels are achieved within 12–15 minutes of administration. Afrezza is available in 4-unit and 8-unit single dose cartridges of insulin powder that can be used, as prescribed by a health care professional, in combination with other diabetes medications to achieve target blood sugar levels. For afrezza doses exceeding 8 units, patients may use a combination of 4 unit and 8 unit cartridges. Other sizes of cartridges are being considered. The disposable inhaler can be used for up to 15 days, should be kept in a clean, dry place with the mouthpiece cover on and may be wiped with a clean, dry cloth if needed.
Limitations of use
Do not use afrezza as a substitute for long-acting insulin;
Afrezza must be used in combination with long-acting insulin in patients with type 1 diabetes.
Do not use afrezza to treat diabetic ketoacidosis. Afrezza is not recommended in patients who smoke or who have recently stopped smoking.
Important safety information for afrezza
Warning: risk of acute bronchospasm in patients with chronic lung disease
Acute bronchospasm has been observed in patients with asthma and COPD using afrezza. Afrezza is contraindicated in patients with chronic lung disease such as asthma or copd. Before initiating afrezza, perform a detailed medical history, physical examination, and spirometry (FEV1) to identify potential lung disease in all patients.
Do not use afrezza if you have problems with your lungs, such as asthma or COPD. Do not use afrezza during a low blood sugar reaction (hypoglycemia). If you are allergic to any of the ingredients in afrezza, do not use afrezza as this may cause a significant and severe allergic reaction.
Afrezza patient starter kit